 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
9-27-2023
Insider Buy |
Craig Fraser
President and CEO |
$1.02
CAGR »
|
$2,549.75
2,500 shares |
9-26-2023
Insider Buy |
Craig Fraser
President and CEO |
$0.90
CAGR »
|
$2,250.00
2,500 shares |
4-26-2023
Insider Buy |
Craig Fraser
President and CEO |
$1.77
CAGR »
|
$2,649.69
1,497 shares |
4-25-2023
Insider Buy |
Craig Fraser
President and CEO |
$1.89
CAGR »
|
$2,485.35
1,315 shares |
7-27-2022
Insider Buy |
Craig Fraser
President and CEO |
$0.38
CAGR »
|
$949.75
2,500 shares |
7-26-2022
Insider Buy |
Craig Fraser
President and CEO |
$0.37
CAGR »
|
$935.00
2,500 shares |
7-26-2022
Insider Buy |
John P. Hamill
SVP & CFO |
$0.37
CAGR »
|
$1,099.80
3,000 shares |
6-29-2022
Insider Buy |
Craig Fraser
President and CEO |
$0.42
CAGR »
|
$2,907.80
7,000 shares |
3-16-2022
Insider Buy |
Craig Fraser
President and CEO |
$0.98
CAGR »
|
$1,959.80
2,000 shares |
3-15-2022
Insider Buy |
Craig Fraser
President and CEO |
$0.98
CAGR »
|
$2,940.30
3,000 shares |
11-19-2021
Insider Buy |
Craig Fraser
President and CEO |
$1.60
CAGR »
|
$1,488.00
930 shares |
10-22-2021
Insider Buy |
Craig Fraser
President and CEO |
$1.90
CAGR »
|
$5,700.00
3,000 shares |
4-16-2021
Insider Buy |
Craig Fraser
President and CEO |
$2.09
CAGR »
|
$2,092.00
1,000 shares |
4-16-2021
Insider Buy |
John P. Hamill
SVP & CFO |
$2.07
CAGR »
|
$2,066.90
1,000 shares |
4-15-2021
Insider Buy |
Craig Fraser
President and CEO |
$2.24
CAGR »
|
$2,239.90
1,000 shares |
4-16-2021
Insider Buy |
John P. Hamill
SVP & CFO |
$2.07
CAGR »
|
$2,066.90
1,000 shares |
4-5-2021
Insider Buy |
Craig Fraser
President and CEO |
$2.58
CAGR »
|
$2,579.90
1,000 shares |
4-1-2021
Insider Buy |
Craig Fraser
President and CEO |
$2.46
CAGR »
|
$1,229.35
500 shares |
3-31-2021
Insider Buy |
James Huang
Director and >10% Owner |
$2.36
CAGR »
|
$354,000.00
150,000 shares |
10-28-2020
Insider Buy |
Craig Fraser
President and CEO |
$6.56
CAGR »
|
$1,639.88
250 shares |
10-23-2020
Insider Buy |
James Huang
Director and >10% Owner |
$6.67
CAGR »
|
$6,666.00
1,000 shares |
6-4-2020
Insider Buy |
James Huang
Director and >10% Owner |
$7.32
CAGR »
|
$87,867.60
12,000 shares |
10-9-2020
Insider Buy |
Craig Fraser
President and CEO |
$5.83
CAGR »
|
$1,456.25
250 shares |
10-8-2020
Insider Buy |
Eric Curtis
SVP & COO |
$5.27
CAGR »
|
$2,635.00
500 shares |
10-7-2020
Insider Buy |
Craig Fraser
President and CEO |
$5.17
CAGR »
|
$1,292.50
250 shares |
10-7-2020
Insider Buy |
John P. Hamill
SVP & CFO |
$5.27
CAGR »
|
$5,270.00
1,000 shares |
5-22-2020
Insider Buy |
Steven Simonson
SVP, Chief Medical Officer |
$7.25
CAGR »
|
$3,748.25
517 shares |
5-22-2020
Insider Buy |
John A. Tattory
SVP & CFO |
$7.25
CAGR »
|
$3,255.25
449 shares |
5-22-2020
Insider Buy |
Mary B. Esq Templeton
SVP, Gen Counsel & Corp Sec |
$7.25
CAGR »
|
$7,996.75
1,103 shares |
5-22-2020
Insider Buy |
Daniel E. Geffken
Director |
$7.25
CAGR »
|
$15,000.25
2,069 shares |
5-22-2020
Insider Buy |
James Huang
Director and >10% Owner |
$7.25
CAGR »
|
$1,999,999.50
275,862 shares |
5-22-2020
Insider Buy |
John R. Leone
Director |
$7.25
CAGR »
|
$15,000.25
2,069 shares |
5-22-2020
Insider Buy |
Mahady M. Joseph
Director |
$7.25
CAGR »
|
$15,000.25
2,069 shares |
5-22-2020
Insider Buy |
Bruce Peacock
Director |
$7.25
CAGR »
|
$25,375.00
3,500 shares |
5-22-2020
Insider Buy |
Brian D. Schreiber
Director |
$7.25
CAGR »
|
$15,000.25
2,069 shares |
2-7-2020
Insider Buy |
James Huang
Director and >10% Owner |
$4.05
CAGR »
|
$2,025.00
500 shares |
1-17-2020
Insider Buy |
James Huang
Director and >10% Owner |
$4.18
CAGR »
|
$8,609.40
2,058 shares |
12-30-2019
Insider Buy |
James Huang
Director and >10% Owner |
$3.74
CAGR »
|
$18,723.95
5,000 shares |
12-6-2019
Insider Buy |
Pharmaceutical Holdings Ltd Lee's
>10% Owner |
$3.02
CAGR »
|
$4,999,999.58
1,655,629 shares |
12-6-2019
Insider Buy |
Investments Ltd Lph II
>10% Owner |
$3.02
CAGR »
|
$4,999,999.58
1,655,629 shares |
12-6-2019
Insider Buy |
James Huang
Director and >10% Owner |
$3.02
CAGR »
|
$4,999,999.58
1,655,629 shares |
12-21-2018
Insider Buy |
Investments Ltd Lph II
>10% Owner |
$3.31
CAGR »
|
$5,994,204.78
1,810,938 shares |
12-21-2018
Insider Buy |
Pharmaceutical Holdings Ltd Lee's
>10% Owner |
$4.00
CAGR »
|
$39,459,227.93
9,874,799 shares |
Also See: Institutional Holders of WINT
Also See: SEC filings
Below we present the annualized performance delivered by WINT stock since 9-27-2023 (the date of the most recent
insider purchase). The performance of the investment from the time WINT insider buying occurred is the ultimate
test of whether insiders were right about WINT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/28/2023 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$17.28 |
|
| End price/share: |
$5.16 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-70.14% |
|
| Annualized Gain: |
-122.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,986.00 |
|
| Years: |
0.57 |
|
WINT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent WINT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding WINT
|
|
Free WINT Email Alerts:
